Safety and Efficacy of HO/03/03 10microg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers (Truheal).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs HO 0303 (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Acronyms Truheal
- 03 Apr 2013 Planned end date changed from 1 Feb 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 03 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jul 2012 Planned End Date 1 Feb 2013 added as reported by ClinicalTrials.gov.